Details of the Drug Reposition

General Information of This Drug (ID: DMK38MV)

Drug Name
Fulranumab   DMK38MV
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Arthralgia DISF68US ME82 Phase 3 [1]
Back pain DISDSMNI ME84.Z Phase 3 [1]
Cancer related pain DISBP0IU MG30 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02336685) Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001. U.S. National Institutes of Health.